JAK Inhibitors: Many Different Compounds Being Trialled For Alopecia Areata
It’s a pretty exciting time in the world of alopecia areata research.
This past weekend, I had the opportunity to hear my colleague dermatologist Dr Brett King of Yale University deliver a very nice first hand account of his work with medications known as the janus kinase (JAK) inhibitors over the past 5 years or so. Dr King described how his patient with alopecia areata back in 2013 lead ultimately to him using tofacitinib as a treatment and how that patient’s successful hair regrowth lead ultimately to an expansion of his work in this area. Dr King shared that there are now at least 7 clinical trials with various JAK inhibitors happening and so we should be hearing a lot more about newer JAK inhibitors in the years to come.
Dr. Jeff Donovan is a Canadian and US board certified dermatologist specializing exclusively in hair loss. To schedule a consultation, please call the Whistler office at 604.283.1887